Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-blind, Randomized, Placebo-controlled Cross Over Study of Inhaled Alginate Oligosaccharide (OligoG) Administered for 28 Days in Subjects With Cystic Fibrosis

NCT02157922 is registered in ClinicalTrials.gov with AlgiPharma AS as lead sponsor.

NCT NCT02157922
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02157922 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-blind, Randomized, Placebo-controlled Cross Over Study of Inhaled Alginate Oligosaccharide (OligoG) Administered for 28 Days in Subjects With Cystic Fibrosis
Lead sponsor
AlgiPharma AS
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2014
Completion date
September 30, 2017
Enrollment
65 (actual)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

cystic fibrosis